Medication use in severe anorexia nervosa: a Danish register-based study
Considering the widespread medication prescription in severe AN despite the lack of specific approved pharmacotherapy for the disorder, evidence-based treatment guidelines are urgently needed. Clinicians should recognise the substantial heterogeneity in severity and comorbidity burden within this population and develop comprehensive and specialised treatment strategies that evaluate risks and treatment needs across all individuals with AN, irrespective of comorbid conditions.
Authors
- Janne Tidselbak Larsen (ORCID: https://orcid.org/0000-0002-0385-1017)
- Lars J. Petersen (ORCID: https://orcid.org/0000-0003-2519-983X)
- Bjarni Jóhann Vilhjálmsson (ORCID: https://orcid.org/0000-0003-2277-9249)
- T. Munk-Olsen
- Z. Zhang
- Hannah Chatwin
- Kathrine Bang Madsen
- Loa Clausen
- Esben Agerbo
Institutions
- Broad Institute (US)
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Stockholm County Council (SE)
- Karolinska Institutet (SE)
- Central Denmark Region (DK)
Publication Details
- Journal
- BMJ Mental Health
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1136/bmjment-2025-302047
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services